Table 3.
Difference in risk of key symptoms 4 months after acute infection Delta and Omicron variants of SARS-CoV-2.
| Delta N = 742 |
Omicron N = 632 |
Difference in risk of symptoms | |
|---|---|---|---|
| Symptom | % (n) | % (n) | % (CI) p |
| Any symptoms | 58% (431) | 54% (341) | −4% (−9, 1) p = 0.124 |
| Fatigue | 38% (279) | 37% (231) | −1% (−6, 4) p = 0.688 |
| Dyspnea | 27% (200) | 22% (141) | −5% (−9, 0) p = 0.046 |
| Cognitive symptoms | 31% (232) | 33% (208) | +2% (−3, 7) p = 0.515 |
| Depression | 18% (131) | 16% (102) | −2% (−5, 2) p = 0.454 |
| Smell/taste problems | 19% (139) | 5% (32) | −14% (−17, −10) p < 0.001 |
CI, 95% confidence interval. Bold font is used to mark statistically significant difference in risk of symptoms.